platinum has been researched along with Ascites in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Fujita, M; Hayashi, M; Ohira, H; Okai, K; Takahashi, A | 1 |
| Chen, Y; Teng, NNH; Westhoff, GL | 1 |
| Bañuelos-Ramírez, JL; Cantón-Romero, JC; Carrillo-Ibarra, S; Castellanos-González, JA; Miranda-Díaz, AG; Rodríguez-Carrizalez, AD; Sifuentes-Franco, S | 1 |
| Bamias, A; Chatziioannou, A; Dimopoulos, MA; Gavalas, NG; Haidopoulos, D; Kostouros, E; Koutsoukos, K; Liontos, M; Lykka, M; Papadodima, O; Pilalis, E; Rodolakis, A; Terpos, E; Thomakos, N; Trachana, SP; Tzannis, K; Vlachos, G | 1 |
| Fujii, M; Kaiga, T; Kanamori, N; Kochi, M; Mihara, Y; Okubo, R; Takayama, T | 1 |
| Akamo, Y; Manabe, T; Mizuno, I; Mohri, N; Shibata, T; Takeyama, H; Terada, J; Ueda, T; Yamamoto, T; Yotsuyanagi, T | 1 |
6 other study(ies) available for platinum and Ascites
| Article | Year |
|---|---|
Acute kidney injury after platinum-based transcatheter arterial chemoembolization and transarterial infusion chemotherapy in patients with hepatocellular carcinoma.
Topics: Acute Kidney Injury; Aged; Antibiotics, Antineoplastic; Ascites; Bilirubin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Cancer, Regional Perfusion; Diabetes Mellitus; Female; Glomerular Filtration Rate; Humans; Incidence; Liver Neoplasms; Male; Platinum; Prognosis; Retrospective Studies; Risk Factors; Serum Albumin, Human; Survival Rate; Treatment Outcome | 2020 |
Targeting Foxm1 Improves Cytotoxicity of Paclitaxel and Cisplatinum in Platinum-Resistant Ovarian Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Drug Synergism; Female; Forkhead Box Protein M1; Humans; Molecular Targeted Therapy; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; RNA, Messenger; Thiostrepton | 2017 |
Markers of Oxidative Stress and Inflammation in Ascites and Plasma in Patients with Platinum-Sensitive, Platinum-Resistant, and Platinum-Refractory Epithelial Ovarian Cancer.
Topics: Adult; Aged; Antioxidants; Ascites; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Drug Resistance, Neoplasm; Female; Humans; Inflammation; Interleukin-6; Isoprostanes; Lipid Peroxides; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Oxidative Stress; Platinum; Tumor Necrosis Factor-alpha | 2017 |
The Development of an Angiogenic Protein "Signature" in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Ascites; Ascitic Fluid; Carboplatin; Female; Humans; Middle Aged; Neovascularization, Pathologic; Ovarian Neoplasms; Platinum; Prognosis; Vascular Endothelial Growth Factor A | 2016 |
Pharmacokinetics of oxaliplatin in gastrointestinal cancer patients with malignant ascites.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Ascites; Ascitic Fluid; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Platinum | 2011 |
[Intraperitoneal administration of carboplatin loaded alpha-tricalcium phosphate (alpha-TCP) particles in rats bearing abdominal carcinomatosis].
Topics: Animals; Antineoplastic Agents; Ascites; Biodegradation, Environmental; Calcium Phosphates; Carboplatin; Disease Models, Animal; Drug Carriers; Infusions, Parenteral; Male; Peritoneal Neoplasms; Platinum; Rats | 1996 |